CT Scans in Screening for Lung Cancer in Current and Former Smokers
CT Scans in Screening for Lung Cancer in Current and Former Smokers
RATIONALE: Screening tests, such as CT scanning, may help doctors find cancer cells early and
 plan better treatment for lung cancer.

 PURPOSE: This clinical trial is studying how well a lung cancer screening program using CT
 scanning works in current and former smokers.
OBJECTIVES:

 -  To assess the feasibility of establishing a lung cancer screening program at the
 University of Nebraska Medical Center using CT scanning in normal study participants
 with at least a 30 pack-year history of cigarette smoking.

 -  To determine if it is possible to screen 100 high-risk individuals with high-resolution
 CT scanning for the presence of suspicious pulmonary nodules.

 -  To compare an effective and definitive work-up on all study participants with abnormal
 results within a defined time period from initial screening.

 OUTLINE: Study participants complete a detailed questionnaire (paper or electronic version)
 at baseline to provide personal and family information for inclusion in the registry
 database. Registry data includes information on participants' medical history, diet,
 lifestyle habits, and any past or current environmental exposures, as well as family history
 of cancer within each participant's extended family tree. An instruction manual on completing
 the questionnaires is provided to all study participants. The System Coordinator of the
 registry may provide additional information or clarification of the information provided in
 the questionnaires via a structured telephone interview. Data on study participants and their
 families is entered into the registry database either manually via the paper-based
 questionnaires or electronically via interactive Web-based questionnaires completed by
 participants through the registry website.

 Study participants also undergo a low-dose spiral CT scan at baseline. The resulting images
 are stored electronically and linked to the web-based participant registry. A radiologist
 then reviews the images, reports on any abnormalities, and renders an interpretation of the
 scan as being positive or negative for lung nodules. The radiologist's findings are then
 conveyed to the study participant's primary care physician and the following determinations
 are made: participants with negative findings (i.e., non-calcified solid nodules < 5 mm or
 non-solid nodules < 8 mm) are returned home and scheduled for a repeat CT scan in 1 year;
 participants with abnormalities not related to lung cancer are referred to their primary care
 physician for further action; and participants with positive findings undergo additional
 diagnostic work-up and treatment* as described below.

 -  Non-calcified solid nodules ≥ 5 and ≤ 15 mm: Study participants undergo a course of
 antibiotics followed by a high-resolution CT scan at 3 months. If the CT findings are
 stable, then participants return for a repeat CT scan in 1 year. If the nodules are
 growing, participants undergo additional diagnostic work-up, which may include biopsy of
 the positive nodule by their treating clinician.

 -  Non-solid nodule ≥ 8 mm: Study participants undergo treatment with an antibiotic, CT
 follow-up, and additional diagnostic work-up, if appropriate, as described previously.

 -  Non-calcified solid nodules > 15 mm: Study participants undergo work-up for a positive
 nodule, as above.

 NOTE: *Study participants who demonstrate radiographic abnormalities that are suspected to be
 of an inflammatory nature are given a 10-day course of a broad spectrum respiratory
 antibiotic, preferably a fluoroquinolone, by the participating physician who enrolled that
 participant into the study.

 Study participants with negative CT findings undergo CT screening once yearly for up to five
 years, in the absence of a diagnosed malignancy. Diagnostic work-up for repeat CT scans is as
 follows:

 -  Any new lesion: Study participants undergo a work-up as previously described for
 non-calcified solid or non-solid nodules.

 -  Any non-calcified nodule that was present earlier and grew in size:

 -  Growth < 3 mm: Study participants undergo a repeat CT scan in 6 months. If there is
 further growth, participants are worked-up for a positive nodule, or, if the scan
 is stable, participants undergo a repeat scan 1 year after the most recent scan.

 -  Growth between 3 mm and 5 mm: Study participants undergo a high-resolution CT scan
 in 3 months and further diagnostic work-up for a positive nodule, as described
 previously, if there is growth. If there is complete resolution of the nodule,
 participants undergo repeat screening CT scan in 1 year after the most recent scan.
 If there is partial resolution of the nodule, another high-resolution CT scan is
 performed 3 months later. Participants with a stable nodule undergo repeat
 screening CT scan 1 year after the most recent scan.

 -  Growth ≥ 5 mm: Study participants receive a course of an antibiotic and undergo
 high-resolution CT scanning after 1 month. The following assessments are also
 performed: work-up for a positive nodule, if there is further growth; repeat
 screening CT scan in 1 year after the most recent scan, if there is complete
 resolution of the nodule; high-resolution CT scan in 3 months, if there is partial
 resolution of the nodule; and repeat screening CT scan 1 year after the most recent
 scan, if the nodule is stable.

 All study participants undergo blood sample collection at baseline for use in future studies.
 Additional blood samples are obtained from study participants with positive CT scans for
 future research on smoking-related diseases. Tissue samples obtained from diagnostic biopsy
 or surgical specimens are also stored for future research.

 Once a malignancy is diagnosed and a definitive intervention is performed, study participants
 are followed periodically thereafter.
DISEASE CHARACTERISTICS:

 -  Current and former smokers with at least a 30 pack-year history of smoking

 PATIENT CHARACTERISTICS:

 -  Body weight less than 140 kg (308 pounds)

 -  Able to lie flat

 -  Able to comply with long-term follow-up

 -  Functional capacity and willingness to undergo diagnostic work-up of suspicious
 nodules and curative therapy if lung cancer is detected

 -  Nursing mothers allowed

 -  No cognitive impairment that would preclude providing informed consent

 -  No other concurrent or prior malignancy within the past five years except superficial
 basal cell carcinoma or nonmelanoma skin cancer

 -  Able to come to clinic for screening

 -  No condition that would preclude screening, diagnosis, or surgical treatment

 -  Not pregnant

 -  Negative pregnancy test

 PRIOR CONCURRENT THERAPY:

 -  Not specified